Navigation Links
ERT Opens Registration for Tokyo Conference on Clinical Outcome Assessment Data Capture
Date:9/10/2013

Tokyo, Japan (PRWEB) September 10, 2013

ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today opened registration for its PROFICIENCY conference in Tokyo, Japan. The conference, which takes place October 24, 2013 at the Hotel Okura Tokyo, focuses on developing, implementing, and justifying effective strategies for collecting high quality Clinical Outcome Assessment (COA) data in clinical research.

“Biopharmaceutical researchers throughout Japan and Asia are eager to learn how COA data can help them meet their clinical objectives,” said Akiyoshi Uchiyama, M.D., Ph.D., former board member and deputy director of GlaxoSmithKline Japan. “This PROFICIENCY conference comes at a time of great interest in this area and should prove very valuable to those who attend.”

The one-day conference is designed to answer the questions that biopharmaceutical researchers have about using COA and electronic COA (eCOA) in Japanese-based clinical trials. A faculty of international regulators, biopharmaceutical professionals and industry experts will present case studies and strategic/tactical information related to:

  •     The current regulatory landscape for COA and eCOA
  •     The effective use of electronic Patient Reported Outcomes (ePRO) in worldwide (including Asian) clinical trials
  •     Addressing the social problem of suicide and assessing Suicidal Ideation & Behavior (SIB) in clinical trials for new drug development

“The Tokyo PROFICIENCY conference offers Japanese researchers an opportunity to network with leading industry and regulatory professionals while advancing their knowledge of the strategic and tactical issues pertaining to patient safety and efficacy data collection in their clinical trials,” said Dr. Jean Paty, ERT’s Chief Regulatory and Scientific Advisor, Outcomes. “We’re very excited to address these important topics and to extend this educational opportunity to our Japanese colleagues.”

For more information and to register for the meeting, please visit http://www.ertjapan.jp.

About ERT
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle. ERT delivers the most widely deployed solutions in centralized cardiac safety, respiratory services, suicide risk assessment and Clinical Outcome Assessments (COA) – which includes patient, clinician, and observer reported outcomes. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes, and delivers safety and efficacy data critical to the approval, labeling, and reimbursement of pharmaceutical products. ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Japan, and Germany.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11111552.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tri Hawk International Opens Eastern Door to Asia
2. Athletico Physical Therapy Opens Facility in Orland Park, Illinois
3. Lice Troopers Opens First South Florida Location in Bay Harbor Islands, FL
4. The Nancy P. Anschutz Center Opens in Northeast Park Hill - A Community’s Vision Realized
5. UNE Opens Doors to Inaugural Class of First Dental School in Northern New England
6. Fitness Franchise Opens New Colorado, Littleton Boot Camp Location
7. Medical Device Consultancy Emergo Group Opens Offices in Turkey and South Africa
8. Harrisburg Law Firm Opens Doors to Eon Mini IPG Allegedly Injured Parties
9. Registration Opens for the 7th International Congress on 3D Dental Imaging: From Scan to Plan to Treat
10. Multi-Million Dollar NICU Opens at North Central Baptist Hospital
11. Athletico Physical Therapy Opens in Greenfield, Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... people suffering from acne, access to quality care can be limited while the desire ... company that offers customized prescription acne care for every customer online, today released its ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive porcelain ... smile.” The National Association of Dental Laboratories (NADL) is informing dentists about the ... of when utilizing dental laboratories and technicians that create these veneers. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency in mind, Patten ... , The seed processing plant opened in Marshallville in 2006, and a bagging and ... allows opportunity for transition of Patten Seed operations to the Middle Georgia location from ...
(Date:3/28/2017)... ... , ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. “A ... his parents and teachers had asked of him that he had neglected to do, but ... the Almighty Creator. There were some who would have felt themselves to be special and ...
(Date:3/27/2017)... , ... March 27, 2017 , ... New patients who ... replace their missing teeth can now have them placed by Dr. Manju Kejriwal, with ... i-CAT® Cone Beam technology to increase the accuracy of each dental implant placement. The ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... Office (JPO) for the composition of matter of ... the treatment or prevention of fibrotic disorders, including ... retinopathy (Japanese Patent #: 6060071).  This patent includes ...
(Date:3/28/2017)... SAN FRANCISCO , March 28, 2017 ... is expected to reach USD 8.0 billion by 2025, ... Inc. The increasing incidence of infectious diseases and cancer ... for use in disease diagnosis over the coming years. ... the usage of autologous and allogenic stem cell therapy, ...
(Date:3/28/2017)... , March 28, 2017 Elysium ... with Cambridge academic ...   The Milner Therapeutics Institute today announces Elysium ... Health has committed significant investment for collaborative projects with academic ... four years. This is the first major research investment outside ...
Breaking Medicine Technology: